Form 10-Q · Quarterly report
Vertiv 10-Q, filed Jul 29, 2026
- Filed
- CIK
- 0001674101
- Accession no.
- 0001628280-26-050609
Summary
Vertiv reported second-quarter 2026 net sales of $3.27 billion, up 24.1% from a year earlier, and net income of $497.8 million, up 53.5%, citing robust data-center demand tied to AI and high-performance computing. The company said it has begun submitting refund claims for tariffs imposed under IEEPA after the U.S. Supreme Court invalidated them in February 2026, adding that the amount, timing and likelihood of any recovery remain uncertain.
Key points
- Gross profit was $1,234.9 million, or 37.7% of sales, versus $896.6 million, or 34.0%, a year earlier.
- Segment net sales rose 29.2% in the Americas to $2,070.8 million, 28.5% in Asia Pacific to $719.9 million, and 1.7% in Europe, Middle East & Africa to $483.6 million.
- Second-quarter capital investments were significantly higher than in the same quarter of 2025, with further global capacity investment anticipated.
- Vertiv said customers are shifting toward higher-density infrastructure, including hybrid air and liquid cooling architectures and high-voltage direct current power architectures.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION Overview We are a global leader in the design, manufacturing and servicing of critical digital infrastructure technology that powers, cools, deploys, secures and maintains electronics that process, store and transmit data. We primarily provide this technology to data centers, communication networks and commercial and industrial environments worldwide. We aim to help create a world where critical technologies always work, and where we empower the vital applications of the digital world. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.